This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
John Wiley & Sons, Ltd. Managerial and Decision Economics Contact information of
John Wiley & Sons, Ltd.: http://www3.interscience.wiley.com/cgi-bin/jhome/7976 Pricing
information: individual rates available on request Editor:
For technical questions regarding this series, please contact
(Christopher F. Baum) Series handle: repec:wly:mgtdec
More pages of listings: 0 |1 |2 |3 2009, Volume 30, Issue 8
2009, Volume 30, Issue 7 2009, Volume 30, Issue 6 2009, Volume 30, Issue 5 2009, Volume 30, Issue 4 2009, Volume 30, Issue 3 2009, Volume 30, Issue 2 2009, Volume 30, Issue 1 2008, Volume 29, Issue 2-3 2008, Volume 29, Issue 8 2008, Volume 29, Issue 7 2008, Volume 29, Issue 6 2008, Volume 29, Issue 5 2008, Volume 29, Issue 4 2008, Volume 29, Issue 1 2007, Volume 28, Issue 4-5 229-229 Editorial by John A. Vernon & Richard L Manning [Downloadable!]
231-250 Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion by Ernst R. Berndt & Patricia M. Danzon & Gregory B. Kruse [Downloadable!]
251-265 'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets by David Reiffen & Michael R. Ward [Downloadable!]
267-283 Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost by F.M. Scherer [Downloadable!]
285-291 Commentary by Joseph A. DiMasi [Downloadable!]
293-306 The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions by Thomas A. Abbott & John A. Vernon [Downloadable!]
307-328 Mergers and acquisitions in the pharmaceutical and biotech industries by Patricia M. Danzon & Andrew Epstein & Sean Nicholson [Downloadable!]
329-351 Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry by Darren Filson & Neal Masia [Downloadable!]
353-355 Commentary by Joseph Golec [Downloadable!]
357-370 Determinants of drug prices and expenditures by William S. Comanor & Stuart O. Schweitzer [Downloadable!]
371-392 Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health' by Frank R. Lichtenberg & Suchin Virabhak [Downloadable!]
393-405 An industrial organization perspective on the influenza vaccine shortage by F.M. Scherer [Downloadable!]
407-413 Drug and vaccine pricing and innovation: what is the story? by Mark V. Pauly [Downloadable!]
415-435 A primer on the economics of re-importation of prescription drugs by Ernst R. Berndt [Downloadable!]
437-438 Commentary by Tomas J. Philipson [Downloadable!]
439-451 Entry and competition in generic biologics by Henry G. Grabowski & David B. Ridley & Kevin A. Schulman [Downloadable!]
453-454 Commentary by Tomas J. Philipson [Downloadable!]
455-465 Product differentiation, competition and regulation of new drugs: the case of statins in four European countries by Panos Kanavos & Joan Costa Font & Alistair McGuire [Downloadable!]
467-468 Commentary by Tomas J. Philipson [Downloadable!]
469-479 The cost of biopharmaceutical R&D: is biotech different? by Joseph A. DiMasi & Henry G. Grabowski [Downloadable!]
481-483 New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003 by Joseph Golec & John A. Vernon [Downloadable!]
485-490 Benefits and costs of newer drugs: an update by Frank R. Lichtenberg [Downloadable!]
491-502 Generic competition and market exclusivity periods in pharmaceuticals by Henry G. Grabowski & Margaret Kyle [Downloadable!]
503-507 The role of different types of health insurance on access and utilization: comparative results on two chronic conditions (hypertension and diabetes type II without complication) by Christine Huttin [Downloadable!]
509-520 Rx Roulette: combatting counterfeit pharmaceuticals in developing nations by Kristina M. Lybecker [Downloadable!]
521-522 The truth about the drug companies, by Marcia Angell, Random House: New York, 2004. xx +305 pp., $24.95 by F.M. Scherer [Downloadable!]
2007, Volume 28, Issue 8 2007, Volume 28, Issue 7 2007, Volume 28, Issue 6 2007, Volume 28, Issue 3 2007, Volume 28, Issue 2 83-91 The strategic use of managerial incentives in a non-profit firm mixed duopoly by Gregory E. Goering [Downloadable!]
93-105 If you play well they will come-and vice versa: bidirectional causality in major-league baseball by Ira Horowitz [Downloadable!]
107-113 Investment in organizational capital by Orlando Gomes [Downloadable!]
115-128 Credible collusion in multimarket oligopoly by Timothy L. Sorenson [Downloadable!]
129-143 Bank monitoring, managerial ownership and Tobin's Q: an empirical analysis for India by Saibal Ghosh [Downloadable!]
145-155 Firm governance and duopoly: in weakness may lie strength by Malcolm P. Brady [Downloadable!]
157-158 The paradox of inelastic sports pricing by Philip K. Porter [Downloadable!]
159-160 Reply to 'the paradox of inelastic sports pricing' by Rodney Fort [Downloadable!]
161-168 A further clarification of OCRA and its properties in response to Wang and Wang (2005) by Celik Parkan [Downloadable!]
169-170 Notorious murders, black lanterns, & moveable goods: the transformation of Edinburgh's underworld in the early nineteenth century, by Symonds, D. A., Series on International Political and Economic History, University of Akron Press: Akron, OH; 2006, xiv+180pp., USD 39.95 (cloth) by William F. Shughart [Downloadable!]
2007, Volume 28, Issue 1 1-12 Rural Internet access: over-subscription strategies, regulation and equilibrium by SeungJae Shin & Martin B. Weiss & Jack Tucci [Downloadable!]
13-26 Efficient organization of information processing by Jacek Cukrowski & Manfred M. Fischer [Downloadable!]
27-40 Patterns of corporate governance and technical efficiency in Italian manufacturing by Sergio Destefanis & Vania Sena [Downloadable!]
41-55 Preliminary evidence on the appointment of institutional solutions to franchisor moral hazard-the case of franchisee councils by Olivier Cochet & Thomas Ehrmann [Downloadable!]
57-70 Hidden monopsony rents in winner-take-all markets-sport and economic contribution of Spanish soccer players by Pedro Garcia-del-Barrio & Francesc Pujol [Downloadable!]
71-76 Correction of errors in Vetschera's (2004) model of behavioral uncertainty and investment by G.A. Tularam & A.S. Soomro [Downloadable!]
77-78 Response to Tularam and Soomro by Rudolf Vetschera [Downloadable!]
79-80 Handbook of sports economics research, edited by Fizel, J. Armonk, NY and London: M.E. Sharpe, 2006, Viii+280pp., USD 75.95 (cloth) by John Charles Bradbury [Downloadable!]
81-82 Contract theory, by Bolton, P. and Dewatripont, M. MIT Press: Cambridge and London. 2005, xvi+724 pp., USD 65.00 (cloth) by Atin Basuchaudhary [Downloadable!]
2006, Volume 27, Issue 2-3 2006, Volume 27, Issue 8 2006, Volume 27, Issue 7 2006, Volume 27, Issue 6 2006, Volume 27, Issue 5 0 |1 |2 |3 Access
and download statistics
Did you know? There is a FAQ (frequently asked questions).
This page was last updated on 2009-11-1.
IDEAS at the Department of Economics , College of Liberal Arts and Sciences , University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics .